Allergen-induced coexpression of bFGF and TGF-β1 by macrophages in a mouse model of airway remodeling: BFGF induces macrophage TGF-β1 expression in vitro

International Archives of Allergy and Immunology

Volumn 155, Issue 1, 2011, Pages 12-22

  Yum, Hye Young ^a,b   Cho, Jae Youn ^a   Miller, Marina ^a   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Seoul Medical Center   (South Korea)

Author keywords

Allergy; Basic fibroblast growth factor; Eosinophils; Transforming growth factor 1

Indexed keywords

ALLERGEN; BASIC FIBROBLAST GROWTH FACTOR; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR RECEPTOR 1; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; BRONCHUS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMAGE ANALYSIS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENAL CORTEX HORMONES; AIRWAY REMODELING; ALLERGENS; ANIMALS; ANTIGENS, DIFFERENTIATION; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; LEUKOCYTES, MONONUCLEAR; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSFORMING GROWTH FACTOR BETA1; VACCINATION;

EID: 78649319089     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317213     Document Type: Article

References (32)

1. Broide DH: Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 2008;121:560-570. (Pubitemid 351323873)
2. Bosse Y, Rola-Pleszczynski M: FGF-2 in asthmatic airway-smooth-muscle- cell hyperplasia. Trends Mol Med 2008;14:3-11.
3. Bosse Y, Thompson C, Stankovz J, Rola-Pleszczynski M: Fibroblast growth factor 2 and transforming growth factor β 1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2006;34:746-753. (Pubitemid 43825340)
4. Strutz F, Seisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Muller GA: TGF-β 1 induced proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 2001;59:579-892.
5. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995;9:919-925.
6. Shute JK, Solic N, Shimizu J, McConnel W, Redington AE, Howarth PH: Epithelial expression and release of FGF-2 from heparin sulphate binding sites in bronchial tissue in asthma. Thorax 2004;59:557-562. (Pubitemid 38901512)
7. Kanazawa H, Yoshikawa J: Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest 2007;132:1169-1174. (Pubitemid 47620989)
8. Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, Holgate ST, Howarth PH: Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384-387. (Pubitemid 32173920)
9. Itoh N, Ornitz DM: Evolution of the FGF and FGFR gene families. Trends Genet 2004;20:563-569. (Pubitemid 39314564)
10. Itoh N, Ornitz DM: Functional evolutionary history of the mouse FGF gene family. Dev Dyn 2008;237:18-27.
11. Klint P, Claesson-Welsh L: Signal transduction by fibroblast growth factor receptors. Front Biosci 1999;4: D165-D177.
12. Kwabi-Addo B, Ozen M, Ittmann M: The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 2004;11:709-724. (Pubitemid 40065546)
13. Powers CJ, McLeskey SW, Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-197.
14. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-840.
15. Qu Z, Kayton RJ, Ahmadi P, Liebler JM, Powers MR, Planck SR, Rosenbaum JT: Ultrastuctural immunolocalization of basic fibroblast growth factor in mast cell secretory granules: morphological evidence for bFGF release through degranulation. J Histochem Cytochem 1998;46:1119-1128. (Pubitemid 28445286)
16. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is release by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992;151:81-93.
17. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991;88:11007-11011. (Pubitemid 21915968)
18. Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH: Inhibition of allergeninduced airway remodeling in Smad 3-deficient mice. J Immunol 2007;178:7310-7316. (Pubitemid 46847458)
19. McMillan SJ, Xanthou G, Lloyd CM: Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 2005;17:5774-5780. (Pubitemid 40593221)
20. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Friedman S, Broide DH: Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004;113:551-560. (Pubitemid 38542504)
21. Cho JY, Miller M, Baek KJ, Han JW, Nayay J, Lee SY, McElwain K, McElwain S, Raz E, Broide DH: Immunostimulatory DNA reverses established allergen-induced airway remodeling. J Immunol 2004;173:7556-7564. (Pubitemid 39628197)
22. Cho JY, Miller M, McElwain S, Broide DH: Combination of corticosteroid therapy and allergen avoidance reverses allergen-induced airway remodeling in mice. J Allergy Clin Immunol 2005;116:1116-1122. (Pubitemid 41571797)
23. Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301. (Pubitemid 32173907)
24. Alcorn J, Rinaldi L, Jaffe E, van Loon M, Bates J, Janssen-Heininger Y, Irvin C: Transforming growth factor-β 1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 2007;176:974-982. (Pubitemid 350127840)
25. Fattouh R, Midence G, Arias K, Johnson H, Walker T, Concharova S, Souza K, Gregory R, Lonning S, Gauldie J, Jordana M: Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008;177:593-603. (Pubitemid 351442166)
26. Jeon SG, Lee CG, Oh MH, Chun EY, Gho YS, Cho SH, Kim JH, Min KU, Kim YY, Kim YK, Elias JA: Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J Allergy Clin Immunol 2007;119:831-837. (Pubitemid 46527820)
27. Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, Brann DW: Induction of transforming growth factor-β 1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation. J Neurosci Res 2007;85:1033-1045. (Pubitemid 46580344)
28. Kawai-Kowase K, Sato H, Oyama Y, Kanai H, Sate M, Doi H, Kurabayashi M: Basic fibroblast growth factor antagonizes transforming growth factor-β 1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 2004;24:1384-1390. (Pubitemid 39050429)
29. Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara K: Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta - simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997;237:292-296. (Pubitemid 27406022)
30. Vignola AM, Chanez P, Chiappara G, Merendino A, Zinnati E, Bousquet J, Bellia V, Bonsignore G: Release of transforming growth factor-beta (TGF-β) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996;106:114-119. (Pubitemid 26329389)
31. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N, Robinson D, Kay AB: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029-1036. (Pubitemid 38056318)
32. Balzar S, Chu HW, Silkoff P, Cundall M, Trudeau JB, Strand M, Wenzel S: Increased TGF-β 2 in severe asthma with eosinophilia. J Allergy Clin Immunol 2005;115:110-117. (Pubitemid 40075429)